STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
297
13F, latest reported quarter
What the filings say about RNR
Insiders, 180 days
-$8.8M net sold
3 sellers · 44% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$6.7M
4 notices
Renaissancere insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, RENAISSANCERE HOLDINGS LTD insiders sold a net $8.8M of stock across 71 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
11 earlier Form 4 trades (code P or S) here by this insider (4 buys, 7 sales), the last on Aug 26, 2026.
The trade is 2.9% of the 160,991 shares held after it.
No other insider sold within 30 days.
297 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP,Chief Portfolio Officer Curtis Ross sold about $1.5M of RNR under a 10b5-1 plan on Sep 3, 2026; 297 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (4 buys, 7 sales), the last on Aug 26, 2026.
The trade is 3.2% of the 155,991 shares held after it.
No other insider sold within 30 days.
297 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP,Chief Portfolio Officer Curtis Ross sold about $1.7M of RNR under a 10b5-1 plan on Sep 3, 2026, the largest insider sale at the company since 2025; 297 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (4 buys, 6 sales), the last on Aug 24, 2026.
The trade is 0.2% of the 165,614 shares held after it.
1 other insider sold within 30 days.
297 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP,Chief Portfolio Officer Curtis Ross sold about $126.3K of RNR under a 10b5-1 plan on Aug 26, 2026; 1 other insider sold within 30 days and 297 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (4 buys, 5 sales), the last on Aug 17, 2026.
The trade is 3.0% of the 165,991 shares held after it.
1 other insider sold within 30 days.
297 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP,Chief Portfolio Officer Curtis Ross sold about $1.6M of RNR under a 10b5-1 plan on Aug 24, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days and 297 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (4 buys, 4 sales), the last on Feb 5, 2026.
The trade is 2.9% of the 170,991 shares held after it.
1 other insider sold within 30 days.
297 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP,Chief Portfolio Officer Curtis Ross sold about $1.6M of RNR on Aug 17, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days and 297 funds added in the latest 13F quarter.
71 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
RNR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Ross Curtis
Filed 2026-09-03
$3.2M
Ross Curtis
Filed 2026-08-26
$126.3K
Ross Curtis
Filed 2026-08-24
$1.6M
Ross Curtis
Filed 2026-08-17
$1.6M
Qutub Robert
Filed 2026-07-28
$1.7M
RNR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON CONSUMER SELECT
$1.2M position · as of 2026-06-30
4.7%
Invesco KBW Property & Casualty Insurance ETF
$9.2M position · as of 2026-05-31
3.8%
Davis Financial Fund
$40.7M position · as of 2026-06-30
3.5%
Davis Financial Portfolio
$2.0M position · as of 2026-06-30
3.5%
Davis Select Financial ETF
$14.2M position · as of 2026-07-31
3.0%
Invesco S&P MidCap 400 GARP ETF
$11.6M position · as of 2026-07-31
2.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Kevin J. O’Donnell
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$13.0M
$25.3M
$5.1M
+76%
+122%
2024
$11.7M
$27.9M
$4.6M
+55%
+103%
2023
$23.7M
$30.2M
$4.9M
+21%
+52%
2022
$10.2M
$10.2M
$3.4M
+13%
+37%
2021
$8.9M
$8.2M
$3.0M
+3%
+20%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.8M sold by insiders over 180 days, 297 funds added last quarter, $6.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt RNR
FY Dec 2025
1.59x
FY Dec 2024
2.21x
FY Dec 2023
0.98x
FY Dec 2022
1.37x
FY Dec 2021
1.06x
Jun 2026
1.55x
Mar 2026
1.81x
Dec 2025
1.59x
Sep 2025
1.79x
Jun 2025
1.72x
Mar 2025
1.32x
Dec 2024
2.21x
Sep 2024
2.01x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+23.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity RNR
FY Dec 2025
+24.2%
FY Dec 2024
+18.7%
FY Dec 2023
+34.7%
FY Dec 2022
-17.8%
FY Dec 2021
-0.6%
Jun 2026
+23.3%
Mar 2026
+25.7%
Dec 2025
+24.2%
Sep 2025
+15.2%
Jun 2025
+19.0%
Mar 2025
+16.6%
Dec 2024
+18.7%
Sep 2024
+38.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RNR
FY Dec 2025
+5.1%
FY Dec 2024
+3.8%
FY Dec 2023
+6.0%
FY Dec 2022
-3.0%
FY Dec 2021
-0.1%
Jun 2026
+4.8%
Mar 2026
+5.2%
Dec 2025
+5.1%
Sep 2025
+3.2%
Jun 2025
+3.8%
Mar 2025
+3.2%
Dec 2024
+3.8%
Sep 2024
+7.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital RNR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed RNR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
5.89x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing RNR
FY Dec 2025
4.98x
FY Dec 2024
7.04x
FY Dec 2023
3.70x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
5.30x
Mar 2026
4.98x
Dec 2025
4.98x
Sep 2025
7.01x
Jun 2025
6.16x
Mar 2025
7.58x
Dec 2024
7.04x
Sep 2024
3.83x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$15.6B
market value at close 2026-10-26 on 2026-07-20 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value RNR
FY Dec 2025
$13.6B
FY Dec 2024
$13.1B
FY Dec 2023
$10.1B
FY Dec 2022
$8.0B
FY Dec 2021
$7.1B
Jun 2026
$14.5B
Mar 2026
$13.7B
Dec 2025
$13.6B
Sep 2025
$12.5B
Jun 2025
$12.7B
Mar 2025
$12.9B
Dec 2024
$13.1B
Sep 2024
$14.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield RNR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.07x
P/E over trailing EPS growth of 89%: four quarters to 2026-03-31 against the four to 2025-03-31
PEG, trailing RNR
FY Dec 2025
0.08x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.06x
Mar 2026
0.06x
Dec 2025
0.08x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
RNR ranks highest on profitability (74th percentile) and institutional and government (74th), and lowest on insider conviction (21st), among Insurance peers.
Profitability
74
Inputs
Return on equity+23.3% · 79 pct, sector of 116
Return on assets+4.8% · 69 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
72
Inputs
Debt to equity0.20x · 68 pct, sector of 104
Cash flow to debt1.55x · 76 pct, sector of 97
Growth
51
Inputs
Revenue growth, YoY+9.9% · 51 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
21
Inputs
Net Form 4 buying (codes P and S), 180d-$3.7M · 41 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
74
Inputs
Funds adding, latest quarter297 · 74 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
58
Inputs
Short interest, % of float+3.1% · 55 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.0% · 60 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
RNR filings, in plain words
Are Renaissancere insiders buying or selling RNR?
In the 180 days to 2026-10-28, Renaissancere insiders were net sellers, a net $8.8M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of RNR?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $6.7M of stock; the latest, by Ross Curtis, was filed 2026-09-03.
Read the full summary
In the 180 days to 2026-10-28, Renaissancere insiders were net sellers of RNR, a net $8.8M across purchases and sales reported on Form 4 by 3 sellers. 44% of the 9 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $6.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.